Pleiotrophin (PTN) is a secreted cytokine that is expressed in various cancer cell lines and human tumor such as colon cancer, lung cancer, gastric cancer and melanoma. It plays significant roles in angiogenesis, metastasis, differentiation and cell growth. The expression of PTN in the adult is limited to the hippocampus in an activity-dependent manner, making it a very attractive target for cancer therapy. RNA interference (RNAi) offers great potential as a new powerful therapeutic strategy based on its highly specific and efficient silencing of a target gene. However, efficient delivery of small interfering RNA (siRNA) in vivo remains a significant hurdle for its successful therapeutic application. In this study, we first identified, on a...
International audienceSmall interfering RNA (siRNA) exhibits a high degree of specificity for target...
Transferrin (TF) is widely used as a tumor-targeting ligand for the delivery of anticancer drugs bec...
Potent sequence selective gene inhibition by siRNA 'targeted' therapeutics promises the ultimate lev...
Pleiotrophin (PTN) is a secreted cytokine that is expressed in various cancer cell lines and human t...
Pleiotrophin (PTN) is a secreted cytokine that is expressed in various cancer cell lines and human t...
RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past t...
RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past t...
RNA interference (RNAi) allows the specific knockdown of tumor relevant genes. To induce RNAi, the d...
RNA interference technology has been developed as a potential therapeutic agent for many indications...
Small interfering RNA (siRNA) can specifically silence disease gene expression. This project investi...
Abstract: RNA interference (RNAi) allows the specific knockdown of tumor relevant genes. To induce R...
Non-small cell lung cancer (NSCLC) remains the most common cause of cancer death worldwide due its r...
Abstract. RNA interference (RNAi) is a sequence-specific, post-transcriptional gene silencing mechan...
Prostate cancer (PCa) accounts for a high number of deaths in males with no available curative treat...
Recent breakthroughs in clinical research and deployment of RNAi therapeutics have validated siRNA's...
International audienceSmall interfering RNA (siRNA) exhibits a high degree of specificity for target...
Transferrin (TF) is widely used as a tumor-targeting ligand for the delivery of anticancer drugs bec...
Potent sequence selective gene inhibition by siRNA 'targeted' therapeutics promises the ultimate lev...
Pleiotrophin (PTN) is a secreted cytokine that is expressed in various cancer cell lines and human t...
Pleiotrophin (PTN) is a secreted cytokine that is expressed in various cancer cell lines and human t...
RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past t...
RNA Interference (RNAi) has brought revolutionary transformations in cancer management in the past t...
RNA interference (RNAi) allows the specific knockdown of tumor relevant genes. To induce RNAi, the d...
RNA interference technology has been developed as a potential therapeutic agent for many indications...
Small interfering RNA (siRNA) can specifically silence disease gene expression. This project investi...
Abstract: RNA interference (RNAi) allows the specific knockdown of tumor relevant genes. To induce R...
Non-small cell lung cancer (NSCLC) remains the most common cause of cancer death worldwide due its r...
Abstract. RNA interference (RNAi) is a sequence-specific, post-transcriptional gene silencing mechan...
Prostate cancer (PCa) accounts for a high number of deaths in males with no available curative treat...
Recent breakthroughs in clinical research and deployment of RNAi therapeutics have validated siRNA's...
International audienceSmall interfering RNA (siRNA) exhibits a high degree of specificity for target...
Transferrin (TF) is widely used as a tumor-targeting ligand for the delivery of anticancer drugs bec...
Potent sequence selective gene inhibition by siRNA 'targeted' therapeutics promises the ultimate lev...